The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
Acadia Healthcare Company Inc (NASDAQ: ACHC) closed the day trading at $18.24 up 0.39% from the previous closing price of $18.17. In other words, the price has increased by $0.39 from its previous closing price. On the day, 2.22 million shares were traded. ACHC stock price reached its highest trading level at $18.6 during the session, while it also had its lowest trading level at $17.99.
Ratios:
For a better understanding of ACHC, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.43 and its Current Ratio is at 1.44. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.76.
On August 14, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $26.
Barclays Downgraded its Overweight to Equal Weight on February 28, 2025, whereas the target price for the stock was revised from $43 to $35.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACHC now has a Market Capitalization of 1649703296 and an Enterprise Value of 4184273920. As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.47, and their Forward P/E ratio for the next fiscal year is 7.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 0.53. Its current Enterprise Value per Revenue stands at 1.281 whereas that against EBITDA is 6.675.
Stock Price History:
The Beta on a monthly basis for ACHC is 0.90, which has changed by -0.5438112 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, ACHC has reached a high of $47.08, while it has fallen to a 52-week low of $17.12. The 50-Day Moving Average of the stock is -21.18%, while the 200-Day Moving Average is calculated to be -29.53%.
Shares Statistics:
Over the past 3-months, ACHC traded about 2.79M shares per day on average, while over the past 10 days, ACHC traded about 2540180 shares per day. A total of 92.26M shares are outstanding, with a floating share count of 90.54M. Insiders hold about 1.86% of the company’s shares, while institutions hold 120.34% stake in the company. Shares short for ACHC as of 1761868800 were 11301282 with a Short Ratio of 4.34, compared to 1759190400 on 14164311. Therefore, it implies a Short% of Shares Outstanding of 11301282 and a Short% of Float of 14.57.
Earnings Estimates
. The current market rating for Acadia Healthcare Company Inc (ACHC) reflects the collective analysis of 10.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.4, with high estimates of $0.47 and low estimates of $0.26.
Analysts are recommending an EPS of between $2.44 and $2.26 for the fiscal current year, implying an average EPS of $2.36. EPS for the following year is $2.4, with 11.0 analysts recommending between $2.76 and $1.74.
Revenue Estimates
9 analysts predict $801.91M in revenue for. The current quarter. It ranges from a high estimate of $815.7M to a low estimate of $789M. As of. The current estimate, Acadia Healthcare Company Inc’s year-ago sales were $774.24MFor the next quarter, 9 analysts are estimating revenue of $817.47M. There is a high estimate of $835.1M for the next quarter, whereas the lowest estimate is $795.4M.
A total of 9 analysts have provided revenue estimates for ACHC’s current fiscal year. The highest revenue estimate was $3.3B, while the lowest revenue estimate was $3.28B, resulting in an average revenue estimate of $3.29B. In the same quarter a year ago, actual revenue was $3.15BBased on 12 analysts’ estimates, the company’s revenue will be $3.46B in the next fiscal year. The high estimate is $3.61B and the low estimate is $3.34B.
